TARGET
saveHER3
ERBB3 receptor; emerging ADC target.
also known as: erbb3
drugs
0
catalysts
0
news
14
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Opinion: FDA must ensure American patients can access new and experimental drugsbiospace · 15d ago
- Merck, Daiichi pull lung cancer filing after FDA pushback deals another blow to $4B dealfiercebiotech · 22d ago
- Bristol Myers' partner Biokin says bispecific ADC clears fourth cancer trial in Chinaendpoints · 2mo ago
- J&J pharma leader to retire; Krystal slumps on gene therapy missbiopharma dive · 2mo ago
- Pathos AI pads pipeline with $2.2B Alphamab deal, AstraZeneca pactfiercebiotech · 2mo ago
- ASCO 2026 TNBC Deep Dive: Breast Cancer Experts Preview Practice-Informing Studiesonclive · 5mo ago
- Breast Cancer Experts Preview Abstracts to Watch at the 2026 ESMO Breast Cancer Congressonclive · 5mo ago
Data sources
last refreshed 49m ago
Found something off?
comments(0)
5-min edit window · permanent after that